Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan
Abstract Background Colistin is used to treat multidrug-resistant gram-negative bacteria. Rising colistin resistance worldwide has created challenges in effective treatment and raised treatment costs. Our study aimed to understand the prevalence of colistin resistance in carbapenem-resistant gram-ne...
Saved in:
Main Authors: | Nazia Khursheed, Fareeha Adnan, Moiz Ahmed Khan, Ramlla Hatif |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10535-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating Gram-negative bacilli isolates’ sensitivity to ceftazidime/avibactam
by: Sunali, et al.
Published: (2025-01-01) -
Artesunate, EDTA, and colistin work synergistically against MCR-negative and -positive colistin-resistant Salmonella
by: Yajun Zhai, et al.
Published: (2025-02-01) -
Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01) -
Carbapenem resistance in gram-negative pathogens in an Iranian hospital: high prevalence of OXA-type carbapenemase genes
by: Setareh Mamishi, et al.
Published: (2025-01-01) -
A Multidisciplinary-Based and Bundle Intervention for Controlling Carbapenem-Resistant Organisms in Neurosurgery
by: Zhu W, et al.
Published: (2025-02-01)